Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Shares  >  Nasdaq  >  Acorda Therapeutics Inc    ACOR   US00484M1062

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
06/26/2015 06/29/2015 06/30/2015 07/01/2015 07/02/2015 Date
33.93(c) 33.43(c) 33.33(c) 32.09(c) 32.08(c) Last
614 953 823 076 876 855 801 209 358 748 Volume
-0.82% -1.47% -0.30% -3.72% -0.03% Change
More quotes
Financials ($)
Sales 2015 450 M
EBIT 2015 -4,55 M
Net income 2015 -23,2 M
Finance 2015 14,4 M
Yield 2015 -
Sales 2016 500 M
EBIT 2016 12,6 M
Net income 2016 -20,3 M
Debt 2016 -
Yield 2016 -
PER 2015 -
PER 2016
Capi. / Sales 2015 3,02x
Capi. / Sales 2016 2,75x
Capitalization 1 373 M
More Financials
Company
Acorda Therapeutics, Inc. engages in the identification, development and commercialization of novel therapies that improve neurological function in people with multiple sclerosis, spinal cord injury and other disorders of the nervous system.The company's two main products are Ampyra and Zanaflex... 
More about the company
Surperformance© ratings of Acorda Therapeutics Inc
Trading Rating : Investor Rating :
More Ratings
Latest news on ACORDA THERAPEUTICS INC
07/01 ACORDA THERAPEUTICS : Data on Inhaled Levodopa Therapy CVT-301 Recognized in Blu..
06/29 ACORDA THERAPEUTICS : Reports Data from a Phase 2b Clinical Trial of CVT-301
06/24 ACORDA THERAPEUTICS : CEO Ron Cohen Named BIO Chairman for 2015-2016 Term
06/24 ACORDA THERAPEUTICS : Data on Inhaled Levodopa Therapy CVT-301 Recognized in Blu..
06/23 ACORDA THERAPEUTICS : Highlights Data on Inhaled Levodopa Therapy CVT-301
06/19 ACORDA THERAPEUTICS : Releases Data on Inhaled Levodopa Therapy CVT-301
06/18 ACORDA THERAPEUTICS : Digital Agency StudioPMG Wins Two Hermes Awards
06/16 ACORDA THERAPEUTICS : Other Events, Financial Statements and Exhibits (form 8-K)
More news
Sector news : Bio Therapeutic Drugs
07/02 QUINTILES TRANSNATIONAL : and Quest Diagnostics Launch Q2 Solutions
07/01 QUINTILES TRANSNATIONAL : ’ Second Quarter 2015 Earnings Call Scheduled fo..
06/30 ISIS PHARMACEUTICALS : Webcast Alert: Corporate Presentation at the 2015 Isis Ph..
More sector news : Bio Therapeutic Drugs
News from SeekingAlpha
06/16 Acorda's CVT-301 successful in mid-stage Parkinson's trial
06/02 Acorda suspends Phase 1b cimaglermin alfa study to investigate potential live..
05/27 Acorda Therapeutics projects Plumiaz NDA filing in early 2017
05/03 Acorda Therapeutics' (ACOR) CEO Ron Cohen Discusses on Q1 2015 Results - Earn..
05/01 ACORDA THERAPEUTICS : Will It Be Bought Out?


Comments 
Advertisement
Chart ACORDA THERAPEUTICS INC
Duration : Period :
Acorda Therapeutics Inc Technical Analysis Chart | ACOR | US00484M1062 | 4-Traders
Full-screen chart
Technical analysis trends
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions